These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 37192443)

  • 1. Serum IL-8 as a Determinant of Response to Phosphodiesterase-4 Inhibition in Chronic Obstructive Pulmonary Disease.
    Govoni M; Bassi M; Santoro D; Donegan S; Singh D
    Am J Respir Crit Care Med; 2023 Sep; 208(5):559-569. PubMed ID: 37192443
    [No Abstract]   [Full Text] [Related]  

  • 2. COPD patients with chronic bronchitis and higher sputum eosinophil counts show increased type-2 and PDE4 gene expression in sputum.
    Singh D; Bassi M; Balzano D; Lucci G; Emirova A; Anna Nandeuil M; Jellema G; Afolabi EK; Leaker B; Kornmann O; Michael Beeh K; Watz H; Govoni M
    J Cell Mol Med; 2021 Jan; 25(2):905-918. PubMed ID: 33295083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis.
    Govoni M; Bassi M; Vezzoli S; Lucci G; Emirova A; Nandeuil MA; Petruzzelli S; Jellema GL; Afolabi EK; Colgan B; Leaker B; Kornmann O; Beeh KM; Watz H; Singh D
    Respir Res; 2020 Mar; 21(1):72. PubMed ID: 32197620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study.
    Singh D; Emirova A; Francisco C; Santoro D; Govoni M; Nandeuil MA
    Respir Res; 2020 Sep; 21(1):246. PubMed ID: 32962709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
    Chong J; Leung B; Poole P
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD002309. PubMed ID: 28922692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
    Chong J; Leung B; Poole P
    Cochrane Database Syst Rev; 2013 Nov; (11):CD002309. PubMed ID: 24190161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation.
    Nguyen HO; Salvi V; Tiberio L; Facchinetti F; Govoni M; Villetti G; Civelli M; Barbazza I; Gaudenzi C; Passari M; Schioppa T; Sozio F; Del Prete A; Sozzani S; Bosisio D
    J Transl Med; 2022 May; 20(1):203. PubMed ID: 35538539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease.
    Facchinetti F; Civelli M; Singh D; Papi A; Emirova A; Govoni M
    Front Pharmacol; 2021; 12():740803. PubMed ID: 34887752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD.
    Singh D; Beeh KM; Colgan B; Kornmann O; Leaker B; Watz H; Lucci G; Geraci S; Emirova A; Govoni M; Nandeuil MA
    Respir Res; 2019 Aug; 20(1):180. PubMed ID: 31399091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease.
    Rhee CK; Kim DK
    Korean J Intern Med; 2020 Mar; 35(2):276-283. PubMed ID: 32131571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease.
    Banner KH; Press NJ
    Br J Pharmacol; 2009 Jul; 157(6):892-906. PubMed ID: 19508401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAS-203, an oral phosphodiesterase 4 inhibitor, exerts anti-inflammatory activities in a rat airway inflammation model.
    Demizu S; Asaka N; Kawahara H; Sasaki E
    Eur J Pharmacol; 2019 Apr; 849():22-29. PubMed ID: 30716315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDE4: a novel target in the treatment of chronic obstructive pulmonary disease.
    Michalski JM; Golden G; Ikari J; Rennard SI
    Clin Pharmacol Ther; 2012 Jan; 91(1):134-42. PubMed ID: 22130119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled Phosphodiesterase Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease.
    Singh D; Lea S; Mathioudakis AG
    Drugs; 2021 Nov; 81(16):1821-1830. PubMed ID: 34731461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the development of phosphodiesterase-4 inhibitors.
    Li G; He D; Cai X; Guan W; Zhang Y; Wu JQ; Yao H
    Eur J Med Chem; 2023 Mar; 250():115195. PubMed ID: 36809706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase inhibitors in the treatment of inflammatory diseases.
    Page CP; Spina D
    Handb Exp Pharmacol; 2011; (204):391-414. PubMed ID: 21695650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD.
    Grootendorst DC; Gauw SA; Verhoosel RM; Sterk PJ; Hospers JJ; Bredenbröker D; Bethke TD; Hiemstra PS; Rabe KF
    Thorax; 2007 Dec; 62(12):1081-7. PubMed ID: 17573446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase 4 inhibitors in diabetic nephropathy.
    Ookawara M; Nio Y
    Cell Signal; 2022 Feb; 90():110185. PubMed ID: 34785349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.